期刊文献+

抗凝、抗血小板药物联合应用致消化道出血的临床特点分析 被引量:2

下载PDF
导出
摘要 目的对比抗凝药物、抗血小板药物、联合用药致消化道出血的临床特点。方法采用病例对照研究方法 ,抽取服用抗凝药物、抗血小板药物或联合用药致消化道出血180例,对于消化道出血的临床特点比较分析研究。结果呕血的构成比以抗血小板药物组最高;便血构成比以抗凝药物组最高;大便潜血阳性构成比以联合用药组最高;严重消化道出血的构成比以联合用药组最高;INR≥3的构成比联合用药组最高;Hb<8 g/dl的构成比联合用药组最高(P<0.05)。结论抗凝药物、抗血小板药物、联合用药致消化道出血的临床特点有差异性表现。
作者 胡琳琳 魏华
出处 《中国实用医药》 2014年第20期181-182,共2页 China Practical Medicine
  • 相关文献

参考文献4

  • 1王玲玲,沈薇,DOFFOEL Michel.抗凝和/或抗血小板药物致消化道出血的临床特点及影响因素[J].胃肠病学和肝病学杂志,2011,20(6):542-545. 被引量:18
  • 2Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expertconsensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American collegeof cardiology cardiology foundation task force on clinical expert consensus documents.Circulation, 2008, 118(18) : 1894- 1909.
  • 3Herreros-Herz M. Prevalence des patient sous antivitalmines Kenmedecine generale et modalites et type de prise en charge. thesepour le doctoerat en medicine, Universite Paris Diderot, 2009.
  • 4Chen H, Zhang Y, Wu XY, et al. Investigation of upper gastrointestinal hemorrhage induced by enteric-coated aspirin in treating coronaryheart disease.Chin J Clinicians ( Electronic Edition), 2010, 4(8):1277-1281.

二级参考文献12

  • 1Hashash JG, Shamseddeen W, Skoury A. Gross lower gastrointestinal bleeding in patients on anticoagulant and/or anti-platelet therapy:endoscopic findings, management, and clinical Outcomes [ J]. J Clin Gastroenterol, 2009, 43 ( 1 ) : 36-42.
  • 2Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use : a report of the American college of cardiology foundation task force on clinical expert consensus documents [ J ]. Circulation, 2008, 118 ( 18 ) : 1894-1909.
  • 3Canadian Cardiovascular Society, American Academy of Family Physicians, American College of Cardiology, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST- elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [ J]. J Am Coll Cardiol, 2008, 51 (10) : 210-247.
  • 4Wysowski DK, Nourjah P, Swartz L. Bleeding complications with Warfarin use: a prevalent adverse effect resulting in regulatory action [ J]. Arch Intern Med, 2007, 167(13): 1414-1419.
  • 5Ibanez L, Vidal X, Lvendrel L, et al. Upper gastrointestinal bleeding associated with anti-platelet drugs [ J ]. Aliment Pharmacol Ther, 2006, 23(2) : 235-242.
  • 6Barkun AN, Bardou M, Kuipers EJ. International consensus recommendations on the management of patients with non-variceal upper gastrointestinal Bleeding [ J ]. Ann Intern Med, 2010, 152 ( 2 ) : 101-113.
  • 7Higham J, Kang JY, Majeed A. Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of hemorrhage among older subjects [ J]. Gut, 2002, 50 (4) : 460-464.
  • 8Nalet B, Payen JL, Grasset D, et al. Caracteristiques epidemiologiques et pronostic des h6morragies digestives hautes (HDH) d erigine ulcereuse (HU): 6tude prospective multicentrique de IANGH. XVes Journ6es Nationales de I].NGH Porquerolles, 2007.
  • 9Weil J, Langman MJS, Wainwright P. Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs [J]. Gut, 2000, 46(1): 27-31.
  • 10Herreros-Herz M. Prevalence des patient sous antivitalmines Ken medecine generale et modalites et type de prise en charge [ D ]. these pour le doctoerat en medecine, Universite Paris Diderot,2009 .

共引文献17

同被引文献25

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部